Forth Marc 4

What Happened

• Forth Marc, a director of AEON Biopharma (AEON), was granted 222,684 restricted stock units (RSUs) on June 17, 2026. The Form 4 reports the transaction as an award (code A) at $0.00 per share (total reported value $0).

Key Details

• Transaction date: 2026-06-17 (Form filed 2026-06-22)
• Transaction type/code: Award (A) — 222,684 RSUs; reported price $0.00
• Shares owned after transaction: Not disclosed in this Form 4
• Footnote: RSUs vest in full on the earlier of (i) the one-year anniversary of the grant date or (ii) the date of the 2027 annual meeting, subject to continued service
• Filing timeliness: No late-filing flag indicated in the provided filing

Context

• RSUs are a compensation award that convert into shares only when they vest; they are not an immediate purchase or sale and don’t by themselves indicate the insider buying or selling stock. Vesting is subject to continued service and, when shares vest, there may be tax withholding or subsequent sales reported separately.